Korean Drug Co. Ltd (014570) — Free Cash Flow Generation Index
Korean Drug Co. Ltd (014570) has a Free Cash Flow Generation Index of 0.98x as of September 2025. Free cash flow of ₩3.65 Billion represents 1% of operating cash flow (₩3.72 Billion). See 014570 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Korean Drug Co. Ltd Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for Korean Drug Co. Ltd across 10 annual periods. Explore Korean Drug Co. Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Korean Drug Co. Ltd (2014–2024)
Year-by-year Free Cash Flow Generation Index for Korean Drug Co. Ltd. For the full company profile including market capitalisation, see market cap of Korean Drug Co. Ltd.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.79x | ₩3.83 Billion | ₩4.87 Billion | ₩1.04 Billion | ▲ +923.3% |
| 2022 | -0.10x | ₩-564.37 Million | ₩5.91 Billion | ₩6.09 Billion | ▼ -111.0% |
| 2021 | 0.87x | ₩7.65 Billion | ₩8.81 Billion | ₩1.15 Billion | ▼ -7.5% |
| 2020 | 0.94x | ₩11.57 Billion | ₩12.33 Billion | ₩738.47 Million | ▼ -37.1% |
| 2019 | 1.49x | ₩9.26 Billion | ₩6.21 Billion | ₩3.05 Billion | ▲ +21.8% |
| 2018 | 1.22x | ₩7.09 Billion | ₩5.79 Billion | ₩1.30 Billion | ▼ -65.3% |
| 2017 | 3.53x | ₩1.58 Billion | ₩447.20 Million | ₩1.13 Billion | ▲ +216.4% |
| 2016 | 1.12x | ₩4.42 Billion | ₩3.96 Billion | ₩460.84 Million | ▼ -2.4% |
| 2015 | 1.14x | ₩7.01 Billion | ₩6.13 Billion | ₩878.05 Million | ▲ +2.0% |
| 2014 | 1.12x | ₩5.00 Billion | ₩4.46 Billion | ₩538.19 Million | — |